Anti-VEGF intravitreal injection is the standard of care for patients with neovascular age-related macular degeneration or wet AMD. However, despite effective treatment options, many patients with wet AMD do not receive the recommended number of injections and follow-up visits annually. This retrospective cohort study, published in JAMA Ophthalmology, examined loss to follow-up rates to determine which...